BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

James B. Hickey, Jr. Joins IMRIS Board of Directors


5/31/2013 6:31:39 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WINNIPEG, MB, May 30, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the appointment of James Hickey to the company's board of directors effective June 1, 2013.

Mr. Hickey is an experienced medical device industry executive who brings more than 25 years of experience in building, managing and leading successful medical technology companies. He began his career with American Hospital Supply/Baxter Healthcare in 1977. Subsequently he has served as the CEO of two publicly traded and two private medical device companies and is currently President and CEO of Phraxis, a medical device developer of vascular access products for the dialysis market. From 1998 until 2011, Mr. Hickey served on the board of Vital Images, including having served as the Chair of the Board.

"The addition of Jim to our board brings extensive industry knowledge and leadership experience that will benefit our company, our customers and our shareholders," said David Graves, Chairman of the Board of Directors. "Jim's contribution to the strategic thinking in combination with his broad industry experience will make a meaningful difference to IMRIS."

Mr. Hickey has served on numerous medical device boards and was honored by Twin Cities Business Monthly as one of their "Corporate Directors of the Year" in 2005.

"I am delighted to join the IMRIS' board of directors," said Mr. Hickey. "IMRIS' VISIUS® Surgical Theatre is the leading technology in the market, and with the development of the SYMBIS Surgical Robotic System, has the potential to improve outcomes for patients while reducing the cost of care. I look forward to contributing to the growth of the company."

Mr. Hickey will replace Mr. Robert Courteau who has resigned from the board of directors effective May 31, 2013.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.


SOURCE IMRIS Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

IMRIS
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES